Veronica Hersberger
Chief Tech/Sci/R&D Officer chez AUTOLUS THERAPEUTICS PLC
Profil
Veronica Hersberger is currently the Senior Vice President-Medical Affairs at Autolus Therapeutics Plc since 2023.
Previously, she worked as the Chief Medical Officer at Targimmune Therapeutics AG.
She obtained a doctorate degree from Universidad de Buenos Aires.
Postes actifs de Veronica Hersberger
| Sociétés | Poste | Début |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 01/04/2023 |
Anciens postes connus de Veronica Hersberger
| Sociétés | Poste | Fin |
|---|---|---|
Targimmune Therapeutics AG
 Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | Chief Tech/Sci/R&D Officer | - |
Formation de Veronica Hersberger
| Universidad de Buenos Aires | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AUTOLUS THERAPEUTICS PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
Targimmune Therapeutics AG
Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | Health Technology |
